Reneo Pharmaceuticals Inc
NASDAQ:RPHM

Watchlist Manager
Reneo Pharmaceuticals Inc Logo
Reneo Pharmaceuticals Inc
NASDAQ:RPHM
Watchlist
Price: 1.82 USD 5.2% Market Closed
Market Cap: 2.3B USD
Have any thoughts about
Reneo Pharmaceuticals Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Reneo Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(19)
(22)
(28)
(35)
(40)
(46)
(49)
(49)
(52)
(54)
(61)
(67)
(77)
(71)
(57)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
1
2
3
4
5
5
5
4
4
5
0
0
0
0
Other Non-Cash Items
0
1
2
3
5
5
5
5
4
4
3
2
1
1
0
Change in Working Capital
1
(1)
(4)
(1)
(3)
2
3
3
1
3
7
5
12
(6)
(10)
Cash from Operating Activities
(19)
N/A
(23)
-22%
(29)
-30%
(33)
-13%
(38)
-14%
(38)
-1%
(41)
-6%
(42)
-3%
(47)
-13%
(47)
0%
(52)
-9%
(60)
-15%
(64)
-7%
(76)
-19%
(66)
+12%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
7
2
(26)
(31)
(23)
(18)
18
(23)
(58)
(44)
(122)
(56)
11
6
97
Cash from Investing Activities
7
N/A
2
-71%
(26)
N/A
(32)
-22%
(23)
+26%
(18)
+23%
18
N/A
(23)
N/A
(58)
-154%
(45)
+23%
(123)
-174%
(56)
+54%
11
N/A
6
-45%
97
+1 586%
Financing Cash Flow
Net Issuance of Common Stock
47
95
179
179
132
85
0
0
0
1
65
65
61
60
(4)
Other
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
(0)
Cash from Financing Activities
47
N/A
93
+98%
179
+92%
179
+0%
132
-26%
86
-35%
0
-100%
0
-31%
0
+74%
1
+213%
65
+4 338%
65
+0%
61
-7%
60
-2%
(4)
N/A
Change in Cash
Net Change in Cash
36
N/A
73
+102%
124
+70%
115
-8%
71
-38%
30
-58%
(22)
N/A
(64)
-191%
(105)
-63%
(91)
+13%
(109)
-20%
(50)
+54%
8
N/A
(10)
N/A
27
N/A
Free Cash Flow
Free Cash Flow
(19)
N/A
(23)
-22%
(30)
-30%
(33)
-14%
(38)
-14%
(39)
-1%
(41)
-6%
(42)
-3%
(48)
-14%
(48)
0%
(52)
-9%
(60)
-15%
(64)
-7%
(76)
-18%
(66)
+12%

See Also

Discover More